Logos Global Management »

Nextcure shares owned by Logos Global Management

Quarter-by-quarter ownership of Nextcure (NXTC) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Nextcure

Tip: Access up to 7 years of quarterly data

All positions including Nextcure held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nextcure by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.3M 1.9M 2.23

More positions owned by Logos Global Management

Sarepta Therapeutics (SRPT)
Alnylam Pharmaceuticals Call Option (ALNY)
Ideaya Biosciences (IDYA)
Immunocore Hldgs Ads (IMCR)
Immunovant (IMVT)
Ocular Therapeutix (OCUL)
Structure Therapeutics Sponsored Ads (GPCR)
Olema Pharmaceuticals (OLMA)
Dyne Therapeutics (DYN)
Apellis Pharmaceuticals (APLS)
Rocket Pharmaceuticals (RCKT)
Astria Therapeutics Call Option (ATXS)
Silence Therapeutics Ads (SLN)
Geron Corporation (GERN)
Annexon (ANNX)

View all positions for Logos Global Management

Top funds holding Nextcure

Sofinnova Ventures
Logos Global Management
Affinity Asset Advisors
OrbiMed Advisors
Millennium Management
Vanguard Group
BlackRock
Cable Car Capital
Long Focus Capital Management
Acadian Asset Management
Assenagon Asset Management
Morgan Stanley
Renaissance Technologies
Schonfeld Strategic Advisors
Federated Investors

View all funds holding Nextcure